O-Ring seals are commonly used in the pharmaceutical industry to ensure the integrity of containers and closures. USP 661.27 sets specific requirements for O-Ring seals used in pharmaceutical packaging to ensure they meet the necessary standards for safety and efficacy.

These seals must be made from materials that are compatible with the drug product and should not interact with the contents of the container. They must also be able to maintain their integrity and functionality throughout the shelf life of the product, ensuring that the container remains sealed and secure.

In addition to material compatibility, O-Ring seals for USP 661.27 must also meet specific dimensional requirements to ensure a proper fit within the container or closure. This helps to prevent leaks and contamination, which could compromise the quality of the drug product.

Overall, O-Ring seals play a crucial role in pharmaceutical packaging, helping to maintain the safety and efficacy of drug products. By meeting the requirements set forth in USP 661.27, manufacturers can ensure that their products are packaged securely and in compliance with industry standards.